BioPharmX Enrolling Acne Patients For Phase 2b Topical Minocycline Clinical Trial

BioPharmX Corporation announced that the first subject has been enrolled in its Phase 2b clinical trial assessing the efficacy and safety of BPX-01 for the treatment of acne vulgaris. The study is formally known as the OPAL (tOPicAL Minocycline Gel) study.

BPX-01 is the first fully solubilized, hydrophilic, topical minocycline gel capable of being delivered to...

Articles

BioPharmX Enrolling Acne Patients For Phase 2b Topical Minocycline Clinical Trial

BioPharmX Corporation announced that the first subject has been enrolled in its Phase...

Freedom Laser Therapy Launches Hair Growth System

Freedom Laser Therapy, a Los Angeles-based developer of light therapy products, has...

Merz North America has acquired ON Light Sciences, maker of the DeScribe Transparent...

Multimodal Laser Treatments Safe and Effective

In a study published in Lasers in Surgery and Medicine (August 2016),...

Products

Calming Serum

Formulated for all skin types, RosaLieve Redness Reducing Complex from Jan...

Collagen Activator

StriVectin Multi-Action Restorative Cream accelerates the skin’s natural...

Stem Cell Assistance

Tensage Stem Cell Cream and Eye Cream from Biopelle feature CellPro...

Customized Facial Treatments

Repêchage Fusion Express Bar and Spa Masks Kits allow estheticians to blend...

Blogs

Addressing Employee Tardiness
By Paul Edwards, CEO of CEDR HR Solutions There’s nothing more maddening than knowing your patients are due to arrive at your door at any moment, but because one or more of your employees STILL hasn’t shown up for work, you won’t be able to take the patients back right away. Despite the many...
Instagram Stories
By Jasmine Hill, MBA at Aesthetic Influencer Instagram launched their Snapchat-like feature, Instagram Stories this week. The feature lets you share a series of photos or videos (up to 10 seconds) to your followers that will disappear from view in 24 hours. Some aesthetic offices have already...
BioPharmX Enrolling Acne Patients For Phase 2b Topical Minocycline Clinical Trial

BioPharmX Corporation announced that the first subject has been enrolled in its Phase 2b clinical trial assessing the efficacy and safety of BPX-01 for the treatment of acne vulgaris. The study is formally known as the OPAL (tOPicAL Minocycline Gel) study.

BPX-01 is the first fully solubilized, hydrophilic, topical minocycline gel capable of being delivered to the sebum-rich areas where P. acnes resides, while avoiding systemic exposure. Findings from the Phase 2a safety study—in which subjects were randomized to once-daily treatment with BPX-01 1% minocycline topical gel or a vehicle control—showed that the formulation eliminated more than 90% of acne-causing bacteria after four weeks. No adverse cutaneous effects were observed, no clinically significant hematologic or chemistry alterations occurred, and no minocycline was detected in the plasma at any timepoint. The study’s patient exit survey also indicated 100% satisfaction with the gel’s usability and tolerability.

The 12-week, multicenter, double-blind, three-arm, vehicle-controlled OPAL study expects to enroll 225 people, ages 9 to 40, who have moderate to severe inflammatory, non-nodular acne vulgaris. Safety...

Freedom Laser Therapy Launches Hair Growth System

Freedom Laser Therapy, a Los Angeles-based developer of light therapy products, has introduced the iRestore Hair Growth System, an FDA-cleared at-home device that treats balding and thinning hair in men and women via clinical-strength lasers and light-emitting diodes (LEDs). The noninvasive lasers and red luminous LEDs stimulate miniaturized and dormant hair follicles to combat premature hair loss. The hands-free device can be used to maintain results and promote accelerated healing after hair transplant surgery, or in conjunction with drug-based hair loss treatments such as Minoxidil or Finasteride.

For more information, visit www.irestorelaser.com.

Merz Acquires ON Light Sciences

Merz North America has acquired ON Light Sciences, maker of the DeScribe Transparent PFD (perfluorodecalin) patch for laser tattoo removal. The DeScribe patch is placed over tattoos prior to irradiation, allowing physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session. It also provides optical clearing of tissue, protects the epidermis and inhibits potentially infectious back-splatter and fumes.

“The addition of ON Light Sciences’ innovative technology allows us to better meet the needs of aesthetic practices that focus on energy-based devices,” said Philip Burchard, CEO of Merz Pharma Group. “We have a vision to be the most innovative company in aesthetics, and this acquisition clearly complements our growing and diversified global portfolio, which includes the Ultherapy and Cellfina devices.”

“We look forward to joining Merz and expanding awareness and use of the DeScribe Transparent PFD Patch. We share Merz’s commitment to innovation that directly and positively impacts patient health and welcome the opportunity to be part of its strong product lineup,” said David Sell, president and CEO of ON Light Sciences.

(Current OLS customers should...

AAD Commends FDA for Indoor Tanning Restrictions

The American Academy of Dermatology (AAD) applauds the U.S. Food and Drug Administration (FDA) for proposing new regulations governing indoor tanning, including an age restriction for minors under the age of 18 as well as a risk-acknowledgement form that all adults must sign before using indoor tanning devices.


According to the AAD, statistics show that millions of people tan indoors annually and the risk of developing melanoma increases by 59% for individuals exposed to UV radiation from indoor tanning—the risk increases with each use. If the FDA’s proposed rule becomes final,... more »

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.


The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.


The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »

Cellfina Available in US

Merz Aesthetics has begun commercial shipment of the Cellfina System, indicated for long-term improvement in the appearance of cellulite in the buttocks and thighs, to aesthetic practices in the U.S.


Cellfina combines proprietary technology with minimally invasive subcision to treat the primary structural cause of dimpled cellulite. Results of the procedure last at least two years—in clinical trials, patient satisfaction with their treatment results improved from 94% at one year to 96% at the two-year mark. The most common side effects reported were soreness, tenderness and bruising... more »